Deferred Tax Assets, Valuation Allowance of AYTU BIOPHARMA, INC from 31 Aug 2011 to 30 Jun 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
AYTU BIOPHARMA, INC quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Aug 2011 to 30 Jun 2025.
  • AYTU BIOPHARMA, INC Deferred Tax Assets, Valuation Allowance for the quarter ending 30 Jun 2025 was $136,552,000, a 0.51% decline year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

AYTU BIOPHARMA, INC Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q2 2025 $136,552,000 -$698,000 -0.51% 30 Jun 2025 10-K 23 Sep 2025 2025 FY
Q2 2024 $137,250,000 +$1,296,000 +0.95% 30 Jun 2024 10-K 23 Sep 2025 2025 FY
Q2 2023 $135,954,000 +$6,988,000 +5.4% 30 Jun 2023 10-K 26 Sep 2024 2024 FY
Q2 2022 $128,966,000 +$12,472,000 +11% 30 Jun 2022 10-K 12 Oct 2023 2023 FY
Q2 2021 $116,494,000 +$76,942,000 +195% 30 Jun 2021 10-K 27 Sep 2022 2022 FY
Q2 2020 $39,552,000 +$16,250,000 +70% 30 Jun 2020 10-K 28 Sep 2021 2021 FY
Q2 2019 $23,302,000 +$6,584,000 +39% 30 Jun 2019 10-K 06 Oct 2020 2020 FY
Q2 2018 $16,718,000 -$2,651,000 -14% 30 Jun 2018 10-K 26 Sep 2019 2020 FY
Q2 2017 $19,369,000 +$8,064,000 +71% 30 Jun 2017 10-K 06 Sep 2018 2018 FY
Q2 2016 $11,305,000 +$7,031,000 +165% 30 Jun 2016 10-K 31 Aug 2017 2017 FY
Q2 2015 $4,274,000 30 Jun 2015 10-K 01 Sep 2016 2016 FY
Q3 2012 $125,200 -$15,700 -14% 31 Aug 2012 10-K 29 Nov 2012 2012 FY
Q3 2011 $109,500 31 Aug 2011 10-K 29 Nov 2012 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.